Abstract
Since Rubidomycin or Daunomycin has been used in the treatment of acute leukemias its effectiveness and toxicity have been differently evaluated. It might be profitable to point out a few conclusions drawn from therapeutic trials carried out by the Leukemia Group of E.O.R.T.C. and by Mathe’s group.
President: W. F. Stenfert-Kroese; Responsible for the E.O.R.T.C.: G. Mathé; Secretary: M. Hayat. Members who have cooperated to this trial: ALLEMAGNE: S. Witte, K. Th. Schricker (Medizinische Klinik mit Poliklinik der Universität Erlangen-Nürnberg, Erlangen); BELGIQUE: H. Tagnon, Y. Kenis (Institut Jules Bordet, Bruxelles); P. Bastenie, Ch. Cauchie (Hôpital Saint-Pierre, Bruxelles); FRANCE: J. Bousser, G. Bilski-Pasquier, A. Bernadou, C. M. Blanc, R. Zittoun (Hôpital de l’Hotel-Dieu, Paris); P. Croizat, L. Revol, J. J. Viala (Hôpital Edouard-Herriot, Lyon); G. Mathé, J. L. Amiel, A. Cattan, M. Hayat. F. de Vassal, Cl. Jasmin, Cl. Rosenfeld, J. R. Schlumberger, M. Schneider, L. Schwarzenberg (Service d’Hématologie de l’Institut Gustave-Roussy et Institut de Cancérologie et d’Immunogénétique, 94-Villejuif; GRANDE-BRETAGNE: G. Hamilton Fairley, R. B. Scott, M. Lipsedge (Saint Bartholomew’s Hospital, Londres); HOLLANDE: W. H. Stenfert-Kroese (Rotterdamsch Radiotherapeutisch Instituut, Rotterdam); IRLANDE: J. B. Healy (Saint-Luke’s Hospital, Dublin); ITALIE: R. Bulgarelli, L. Massimo (Istituto G. Caslini, Gênes); L. Bussi, D. Ciprinani (Ospedale Maggiore Ca’Grande, Milan); E. Polli, G. Sala (Istituto de Semeiotica Medica, Milan).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boiron, M., Jaquillat, Cl., Weil, M., Thomas, M., Bernard, J.: Traitement des leucémies aiguës granulocytaires par la rubidomycine. Path. et Biol. 15, 921 (1967).
Mathé, G., Hayat, M., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Amiel, J. L.: Essai de traitement des leucémies aiguës par la rubidomycine (ou daunomycine) seule ou en association. Path. et Biol. 15, 933 (1967).
Children’s cancer group A — Preliminary evaluation of daunomycin in children with acute leukemia. Path. et Biol. 15, 939 (1967).
Mathé, G., Hayat, M., Schwarzenberg, L., Amiel, J. L., Schneider, M., Cattan, A., Schlumberger, J. R., Jasmin, Cl.: Haute fréquence et qualité des rémissions de la leucémie aiguë lymphoblastique chez l’enfant. Arch. franç. Pédiat. 25, 181–188 (1968).
Organisation Européenne de Recherche sur le Traitement du Cancer — Groupe Coopérateur «Leucémies et Hématosarcomes» — Essai de traitement des leucémies aiguës granulocytaires par la daunomycine. J. Europ. Cancer. 5, 339 (1969).
Mathé, G., Schwarzenberg, L., Schneider, M., Schlumberger, J. R., Amiel, J. L., Cattan, A., Jasmin, Cl.: Acute lymphoblastic leukemia treated with a combination of prednisone, vincristine and rubidomycin. Lancet. 2, 380–383 (1967).
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leukemia and Hematosarcoma., Cooperative Group of the European Organisation for Research on the Treatment of Cancer (E.O.R.T.C.). (1970). Rubidomycin (or Daunomycin): A Clinicial Evaluation. In: Mathé, G. (eds) Advances in the Treatment of Acute (Blastic) Leukemias. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 30 . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-35334-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-35334-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-34998-4
Online ISBN: 978-3-662-35334-9
eBook Packages: Springer Book Archive